UCB Acquires Engage To Boost Epilepsy Franchise

Paying $125m Upfront

 
• By Kevin Grogan

The Belgian drugmaker is getting hold of a device that delivers an inhaled formulation of the anxiety drug alprazolam which can rapidly terminate an epileptic seizure 30 seconds after it has begun.

Madeira_Tree
UCB on the acquisition trail again two months after RA Pharma Buy • Source: Shutterstock

More from Deals

More from Business